Research progress on the mechanism of glycolysis in ovarian cancer

被引:12
作者
Li, Chan [1 ]
Liu, Fang-Yuan [1 ]
Shen, Ying [1 ,2 ]
Tian, Yuan [3 ]
Han, Feng-Juan [2 ]
机构
[1] Heilongjiang Univ Tradit Chinese Med TCM, Harbin, Heilongjiang, Peoples R China
[2] Heilongjiang Univ Tradit Chinese Med TCM, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China
[3] Zhejiang Univ Chinese Med, Hangzhou, Zhejiang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
ovarian cancer; glycolysis; hexokinase; phosphofructokinase; pyruvate kinase; CELL-PROLIFERATION; AEROBIC GLYCOLYSIS; METABOLISM; ACID; CHEMOTHERAPY; FIBROBLASTS; RESISTANCE; GROWTH; MYC;
D O I
10.3389/fimmu.2023.1284853
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glycolysis is the preferred energy metabolism pathway in cancer cells even when the oxygen content is sufficient. Through glycolysis, cancer cells convert glucose into pyruvic acid and then lactate to rapidly produce energy and promote cancer progression. Changes in glycolysis activity play a crucial role in the biosynthesis and energy requirements of cancer cells needed to maintain growth and metastasis. This review focuses on ovarian cancer and the significance of key rate-limiting enzymes (hexokinase, phosphofructokinase, and pyruvate kinase, related signaling pathways (PI3K-AKT, Wnt, MAPK, AMPK), transcription regulators (HIF-1a), and non-coding RNA in the glycolytic pathway. Understanding the relationship between glycolysis and these different mechanisms may provide new opportunities for the future treatment of ovarian cancer.
引用
收藏
页数:12
相关论文
共 92 条
  • [51] Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway
    Liu, Yu
    Tong, Lin
    Luo, Yan
    Li, Xin
    Chen, Gaowen
    Wang, Yifeng
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (07) : 6162 - 6172
  • [52] Long non-coding RNA OIP5-AS1 facilitates the progression of ovarian cancer via the miR-128-3p/CCNG1 axis
    Liu, Yuanyuan
    Fu, Xiaomin
    Wang, Xiuyun
    Liu, Yanling
    Song, Xiaoyan
    [J]. MOLECULAR MEDICINE REPORTS, 2021, 23 (05)
  • [53] Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells
    Loar, Paul
    Wahl, Heather
    Kshirsagar, Malti
    Gossner, Gabrielle
    Griffith, Kent
    Liu, J. Rebecca
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (04) : 371.e1 - 371.e8
  • [54] Altered metabolism in cancer
    Locasale, Jason W.
    Cantley, Lewis C.
    [J]. BMC BIOLOGY, 2010, 8
  • [55] Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells
    Lu, Jiaojiao
    Chen, Hong
    He, Fang
    You, Yuanyi
    Feng, Zhaozu
    Chen, Wei
    Li, Xu
    Zhao, Le
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (08) : 1455 - 1463
  • [56] Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
    Mondal, Susmita
    Roy, Debarshi
    Bhattacharya, Sayantani Sarkar
    Jin, Ling
    Jung, Deokbeom
    Zhang, Song
    Kalogera, Eleftheria
    Staub, Julie
    Wang, Yaxian
    Wen Xuyang
    Khurana, Ashwani
    Chien, Jeremey
    Telang, Sucheta
    Chesney, Jason
    Tapolsky, Gilles
    Petras, Dzeja
    Shridhar, Viji
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 178 - 189
  • [57] Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells
    Mukherjee, Abir
    Ma, Yibao
    Yuan, Fang
    Gong, Yongling
    Fang, Zhenyu
    Mohamed, Esraa M.
    Berrios, Erika
    Shao, Huanjie
    Fang, Xianjun
    [J]. NEOPLASIA, 2015, 17 (09): : 723 - 734
  • [58] Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts
    Radhakrishnan, Rangasudhagar
    Ha, Ji Hee
    Jayaraman, Muralidharan
    Liu, Jinsong
    Moxley, Katherine M.
    Isidoro, Ciro
    Sood, Anil K.
    Song, Yong Sang
    Dhanasekaran, Danny N.
    [J]. CANCER LETTERS, 2019, 442 : 464 - 474
  • [59] MicroRNA-195 controlsMICU1 expression and tumor growth in ovarian cancer
    Rao, Geeta
    Dwivedi, Shailendra Kumar Dhar
    Zhang, Yushan
    Dey, Anindya
    Shameer, Khader
    Karthik, Ramachandran
    Srikantan, Subramanya
    Hossen, Nazir
    Wren, Jonathan D.
    Madesh, Muniswamy
    Dudley, Joel T.
    Bhattacharya, Resham
    Mukherjee, Priyabrata
    [J]. EMBO REPORTS, 2020, 21 (10)
  • [60] Epidemiology of ovarian cancer: a review
    Reid, Brett M.
    Permuth, Jennifer B.
    Sellers, Thomas A.
    [J]. CANCER BIOLOGY & MEDICINE, 2017, 14 (01) : 9 - 32